EE297 Pricing Strategies and Trends of FDA Approved NSCLC Therapies From 2018 to 2023
Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.596
https://www.valueinhealthjournal.com/article/S1098-3015(24)00711-3/fulltext
Title :
EE297 Pricing Strategies and Trends of FDA Approved NSCLC Therapies From 2018 to 2023
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)00711-3&doi=10.1016/j.jval.2024.03.596
First page :
Section Title :
Open access? :
No
Section Order :
10075